|Articles|March 1, 2018
- Pharmaceutical Executive-03-01-2018
- Volume 38
- Issue 3
Pharmaceutical Executive, March 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma: Meet Your New Neighborsover 8 years ago
Risk Sharing, Italian Styleover 8 years ago
The Quest to Measure Upover 8 years ago
Full Disclosure Demanded for Pharma Industryover 8 years ago
Setting the Standard: William Soliman, ACMAover 8 years ago
The Law of Unintended Consequencesover 8 years ago
Pricing Turning Point: The Case for Innovating Pharma’s Modelover 8 years ago
Showdown Nears on Europe Research Incentivesover 8 years ago
The Personalized Genetic Profile: It’s Time to Alignover 8 years ago
Country Report: IndiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
2
2026 Pharm Exec Top 50 Companies
3
Who Pays for Tariff Driven Input Cost Increases?
4
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
5